2022
DOI: 10.1016/j.peptides.2022.170834
|View full text |Cite
|
Sign up to set email alerts
|

Crosstalk between incretin hormones, Th17 and Treg cells in inflammatory diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 212 publications
0
3
0
Order By: Relevance
“…In addition, GLP-1RAs were shown to inhibit inflammatory responses and modulate the immune response, with specific activity on the Treg/Th17 axis [ 38 ]. Furthermore, preclinical evidence suggests that incretins suppress cardiac fibrosis and reduce inflammatory cytokine gene expression in a mouse model of experimental autoimmune myocarditis [ 39 ].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, GLP-1RAs were shown to inhibit inflammatory responses and modulate the immune response, with specific activity on the Treg/Th17 axis [ 38 ]. Furthermore, preclinical evidence suggests that incretins suppress cardiac fibrosis and reduce inflammatory cytokine gene expression in a mouse model of experimental autoimmune myocarditis [ 39 ].…”
Section: Discussionmentioning
confidence: 99%
“…The imbalance between the Treg and Th17 ratio plays a pivotal role in the pathogenesis of a wide a wide array of inflammatory diseases [184], tumors [185], autoimmune disorders [186,187], and metabolic conditions [188][189][190]. A sour understanding of the contributions of IL-17-producing Treg and IL-10-producing Th17 in these diseases continues to expand, their associations with conditions such as inflammatory bowel disease (IBD), cancer, nephritis, autoimmune disorders, and others are gradually being unveiled.…”
Section: The Roles Of Il-17-producing Treg and Il-10-producing Th17 I...mentioning
confidence: 99%
“…Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted from enteroendocrine cells that reside within intestine epithelium ( 59 ). Targeting GLP-1 may be an effective therapeutic strategy for Th17/Treg-mediated inflammatory diseases ( 60 ). A clinical research showed that GLP-1 appeared to decrease production of Th17-related cytokines in people with obesity and asthma ( 61 ).…”
Section: Th17 In Endocrine Organsmentioning
confidence: 99%